NVNO

enVVeno Medical Corp NVNO

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.4M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$953.6K total
KINGDON CAPITAL MANAGEMENT, L.L.C.
$387.3K0.0%
CM Management, LLC
$382.5K0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$67.4K0.0%
JPMORGAN CHASE & CO
$59.1K0.0%
VANGUARD FIDUCIARY TRUST CO
$23.4K0.0%
Westside Investment Management, Inc.
$16.3K-4.0%
Mirae Asset Global Investments Co., Ltd.
$5.8KNew
BlackRock, Inc.
$4.4K-77.5%
Tower Research Capital LLC (TRC)
$3.5K-38.9%
WELLS FARGO & COMPANY/MN
$1.2K0.0%
Allied Private Wealth LLC
$978--
Vanguard Global Advisers, LLC
$8250.0%
MORGAN STANLEY
$632-22.4%
OSAIC HOLDINGS, INC.
$740.0%
BARCLAYS PLC
$21New
GROUP ONE TRADING, L.P.
$210.0%
UBS Group AG
$11-99.6%
See all 17 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NVNO

Earnings Per Share

13fpro.ai/company/NVNO

Loading ratio trend…

NVNO key financials by period

Reported revenue, net income and operating margin by fiscal year, from enVVeno Medical Corp's annual filings on SEC EDGAR.

enVVeno Medical Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2019$31.2K$-7.6M—
FY 2018$186.6K$-13.0M—
FY 2017$422.1K$-7.8M—
Source: NVNO filings on SEC EDGAR →

NVNO insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About enVVeno Medical Corp (NVNO): stock profile, AI score and financials

enVVeno Medical Corp (NVNO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NVNO is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.4m in revenue and is scored on the micro-cap board instead. Top institutional holders of NVNO by reported 13-F value include KINGDON CAPITAL MANAGEMENT, L.L.C., CM Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NVNO trades on the Nasdaq exchange and files with the SEC under CIK 1661053. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NVNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for enVVeno Medical Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1661053 →